Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1272P, also known as RNA, U6 small nuclear 1272, pseudogene, is a non-coding RNA gene classified as a pseudogene in the human genome. U6 small nuclear RNA is a highly conserved component of the spliceosome that is essential for pre-mRNA splicing in eukaryotic cells, but pseudogenes such as RNU6-1272P do not encode functional RNAs or proteins. These pseudogenes arise from duplication or retrotransposition events and generally lack biological function, though in some cases, pseudogene transcripts may act in regulatory roles. There is no evidence that RNU6-1272P has a function in splicing or that it is a therapeutic target, nor is it associated with any disease or pharmacologic intervention[3][4]. Notes on correctness: - RNU6-1272P is a pseudogene, not an active molecular target or receptor. - Pseudogene status means it does not produce a functional small nuclear RNA, and no drugs are known to interact with it. - This entry should be flagged as "is_incorrect: true" if the intent is to obtain information on a molecular target with established biological or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1272, pseudogene (RNU6-1272P).